Predictive Oncology Inc. Quarterly Operating Income (Loss) in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Predictive Oncology Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2018 to Q3 2024.
  • Predictive Oncology Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.31M, a 15.5% increase year-over-year.
  • Predictive Oncology Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$13.7M, a 24.6% increase year-over-year.
  • Predictive Oncology Inc. annual Operating Income (Loss) for 2023 was -$14.1M, a 45.9% increase from 2022.
  • Predictive Oncology Inc. annual Operating Income (Loss) for 2022 was -$26M, a 27.4% decline from 2021.
  • Predictive Oncology Inc. annual Operating Income (Loss) for 2021 was -$20.4M, a 19.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$13.7M -$2.31M +$425K +15.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$14.1M -$3.19M +$770K +19.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$14.9M -$4.24M -$772K -22.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$14.1M -$3.92M +$4.04M +50.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$18.1M -$2.74M +$1.39M +33.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$19.5M -$3.96M +$6.57M +62.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$26.1M -$3.46M -$50.9K -1.49% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$26M -$7.96M +$596K +6.96% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$26.6M -$4.13M +$1.36M +24.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$28M -$10.5M -$7.93M -305% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$20.1M -$3.41M +$364K +9.63% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$20.4M -$8.56M +$3.98M +31.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-21
Q3 2021 -$24.4M -$5.49M +$115K +2.05% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$24.5M -$2.6M +$1.17M +31.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$25.7M -$3.78M -$338K -9.84% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$25.4M -$12.5M -$780K -6.63% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$24.6M -$5.61M -$2.16M -62.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$22.4M -$3.77M +$1.33M +26.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$23.7M -$3.44M -$1.1M -47.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$22.6M -$11.8M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 -$3.44M -$1.58M -85.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$5.1M -$3.69M -261% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$2.34M Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-08
Q3 2018 -$1.86M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-15
Q2 2018 -$1.41M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.